Does a normal TMAO concentration reflect the overall balance of intake, microbial production, liver oxidation, and kidney elimination?

A circulating trimethylamine N-oxide (TMAO) result is a downstream, time-specific biomarker. In a 64-year-old woman, a normal value should not be interpreted as a direct readout of diet, gut microbial activity, hepatic FMO3 function, or renal function in isolation.

Clinical interpretation

• Dietary choline and carnitine are inputs to TMAO production, but effects depend on precursor form and individual microbial context. In controlled human challenge studies, choline bitartrate increased TMAO exposure whereas phosphatidylcholine did not.
• Gut microbial conversion of dietary precursors to trimethylamine (TMA) is essential upstream biology. Labeled carnitine produced labeled TMAO in omnivores, but this conversion was absent after broad-spectrum antibiotic treatment.
• The liver enzyme flavin-containing monooxygenase 3 (FMO3) performs the principal oxidation of microbial TMA to TMAO. Thus, circulating TMAO incorporates both microbial substrate production and hepatic conversion.

Renal clearance and sampling

• Kidney elimination is a major determinant of concentration: TMAO is cleared predominantly in urine, and plasma/serum concentrations rise as eGFR or measured GFR falls, with marked elevations in dialysis populations.
• Accordingly, a normal TMAO concentration does not directly demonstrate normal microbial TMA production, low precursor intake, or normal hepatic oxidation; adequate renal clearance can materially lower the measured level.
• Repeated fasting measurements show meaningful within-person variation. One normal result reflects conditions around the sampling time and may not represent usual TMAO exposure.

Bottom line

• The claim is supported: a normal TMAO value represents the contemporaneous net balance of precursor intake, microbiota-dependent TMA generation, hepatic FMO3 oxidation, and predominantly renal excretion—not any single process directly.